Venous Thromboembolism Global Market Report 2025

Venous Thromboembolism Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on venous thromboembolism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for venous thromboembolism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The venous thromboembolism market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Deep Vein Thrombosis; Pulmonary Embolism; Other Types

2) By Treatment: Anti-Clotting Medications;  Mechanical Devices; Thrombolytic Therapy; Other Treatment

3) By End Users: Hospitals; Homecare; Specialty Centers; Other End Users

Subsegments:

1) By Deep Vein Thrombosis (DVT): Proximal DVT; Distal DVT; Asymptomatic DVT

2) By Pulmonary Embolism (PE): Acute PE; Chronic PE; Submassive PE

3) By Other Types: Thrombophlebitis; Superficial Vein Thrombosis; Post-Thrombotic Syndrome

Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; Merck and Co. Inc.; AbbVie Inc.; Bayer AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.


1. Executive Summary
2. Venous Thromboembolism Market Characteristics
3. Venous Thromboembolism Market Trends And Strategies
4. Venous Thromboembolism Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Venous Thromboembolism Growth Analysis And Strategic Analysis Framework
5.1. Global Venous Thromboembolism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Venous Thromboembolism Market Growth Rate Analysis
5.4. Global Venous Thromboembolism Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Venous Thromboembolism Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Venous Thromboembolism Total Addressable Market (TAM)
6. Venous Thromboembolism Market Segmentation
6.1. Global Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deep Vein Thrombosis
Pulmonary Embolism
Other Types
6.2. Global Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-Clotting Medications
Mechanical Devices
Thrombolytic Therapy
Other Treatment
6.3. Global Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Centers
Other End Users
6.4. Global Venous Thromboembolism Market, Sub-Segmentation Of Deep Vein Thrombosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proximal DVT
Distal DVT
Asymptomatic DVT
6.5. Global Venous Thromboembolism Market, Sub-Segmentation Of Pulmonary Embolism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute PE
Chronic PE
Submassive PE
6.6. Global Venous Thromboembolism Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thrombophlebitis
Superficial Vein Thrombosis
Post-Thrombotic Syndrome
7. Venous Thromboembolism Market Regional And Country Analysis
7.1. Global Venous Thromboembolism Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Venous Thromboembolism Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Venous Thromboembolism Market
8.1. Asia-Pacific Venous Thromboembolism Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Venous Thromboembolism Market
9.1. China Venous Thromboembolism Market Overview
9.2. China Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Venous Thromboembolism Market
10.1. India Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Venous Thromboembolism Market
11.1. Japan Venous Thromboembolism Market Overview
11.2. Japan Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Venous Thromboembolism Market
12.1. Australia Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Venous Thromboembolism Market
13.1. Indonesia Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Venous Thromboembolism Market
14.1. South Korea Venous Thromboembolism Market Overview
14.2. South Korea Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Venous Thromboembolism Market
15.1. Western Europe Venous Thromboembolism Market Overview
15.2. Western Europe Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Venous Thromboembolism Market
16.1. UK Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Venous Thromboembolism Market
17.1. Germany Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Venous Thromboembolism Market
18.1. France Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Venous Thromboembolism Market
19.1. Italy Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Venous Thromboembolism Market
20.1. Spain Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Venous Thromboembolism Market
21.1. Eastern Europe Venous Thromboembolism Market Overview
21.2. Eastern Europe Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Venous Thromboembolism Market
22.1. Russia Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Venous Thromboembolism Market
23.1. North America Venous Thromboembolism Market Overview
23.2. North America Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Venous Thromboembolism Market
24.1. USA Venous Thromboembolism Market Overview
24.2. USA Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Venous Thromboembolism Market
25.1. Canada Venous Thromboembolism Market Overview
25.2. Canada Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Venous Thromboembolism Market
26.1. South America Venous Thromboembolism Market Overview
26.2. South America Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Venous Thromboembolism Market
27.1. Brazil Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Venous Thromboembolism Market
28.1. Middle East Venous Thromboembolism Market Overview
28.2. Middle East Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Venous Thromboembolism Market
29.1. Africa Venous Thromboembolism Market Overview
29.2. Africa Venous Thromboembolism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Venous Thromboembolism Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Venous Thromboembolism Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Venous Thromboembolism Market Competitive Landscape And Company Profiles
30.1. Venous Thromboembolism Market Competitive Landscape
30.2. Venous Thromboembolism Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Venous Thromboembolism Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Sanofi-Aventis LLC.
31.3. Bristol-Myers Squibb Company
31.4. GlaxoSmithKline plc.
31.5. Eli Lilly and Co Ltd.
31.6. Boehringer Ingelheim International GmbH
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Daiichi Sankyo Company Limited
31.9. Sun Pharmaceutical Industries Limited
31.10. Otsuka Pharmaceutical Co. Ltd.
31.11. Menarini Group
31.12. Ipsen S.A.
31.13. Dr. Reddy's Laboratories Ltd.
31.14. Apotex Inc.
31.15. Hikma Pharmaceuticals PLC
32. Global Venous Thromboembolism Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Venous Thromboembolism Market
34. Recent Developments In The Venous Thromboembolism Market
35. Venous Thromboembolism Market High Potential Countries, Segments and Strategies
35.1 Venous Thromboembolism Market In 2029 - Countries Offering Most New Opportunities
35.2 Venous Thromboembolism Market In 2029 - Segments Offering Most New Opportunities
35.3 Venous Thromboembolism Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings